Severe EBV hepatitis treated with valganciclovir

R. Pisapia, A. Mariano, A. Rianda, A. Testa, A. Oliva, L. Vincenzi

Research output: Contribution to journalArticlepeer-review

Abstract

We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalInfection
Volume41
Issue number1
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Epstein-Barr virus infection
  • Hepatitis
  • Therapy
  • Valganciclovir

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Severe EBV hepatitis treated with valganciclovir'. Together they form a unique fingerprint.

Cite this